What are the differences between heat rash and eczema?

Heat rash (miliaria) and eczema (atopic dermatitis) are two distinct dermatologic conditions with different underlying causes, clinical presentations, and management strategies. Heat rash results from obstruction of eccrine sweat ducts—typically due to prolonged exposure to heat and humidity—leading to retention of sweat within the epidermis or dermis. It commonly presents as discrete, pinpoint papules or vesicles, often described as “prickly” or mildly itchy, and is most frequently seen on areas prone to friction and sweating, such as the neck, upper chest, back, and flexural folds. Miliaria crystallina involves superficial duct obstruction and appears as clear, non-inflammatory vesicles; miliaria rubra—more common in infants and adults in hot environments—involves deeper obstruction and manifests as erythematous papules with surrounding erythema and mild stinging or pruritus.

In contrast, eczema is a chronic, relapsing inflammatory skin disorder rooted in immune dysregulation, epidermal barrier dysfunction, and genetic predisposition (e.g., filaggrin gene mutations). It typically begins in early childhood but may persist into adulthood or present de novo later in life. Clinically, eczema features ill-defined, erythematous, scaly, and lichenified plaques—often intensely pruritic—with predilection for flexural surfaces (antecubital and popliteal fossae), wrists, ankles, and the face (especially in children). Chronic scratching leads to excoriations, crusting, and secondary infection risk. Unlike heat rash, eczema is not triggered by ambient temperature alone but may be exacerbated by environmental allergens, irritants, stress, or dry skin.

Diagnostically, heat rash is primarily clinical and self-limited, resolving rapidly with cooling, reduced occlusion, and improved ventilation. Eczema requires careful history-taking—including family history of atopy—and physical examination; in atypical or refractory cases, patch testing or serum IgE evaluation may support diagnosis. Treatment differs significantly: miliaria management centers on prevention—loose clothing, air conditioning, and avoidance of heavy emollients that may further occlude ducts—while eczema demands a multifaceted approach including regular emollient use, topical corticosteroids or calcineurin inhibitors for flares, and identification and mitigation of triggers. Misdiagnosis can lead to inappropriate therapy—for example, applying potent topical steroids for uncomplicated miliaria—or delayed control of chronic inflammation in eczema.